In 2018, Changsheng Bio-technology Co., Ltd. (Changsheng), a leading biopharmaceutical company and one of the market leaders in vaccines, was found to have falsified its production and inspection data and to have sold substandard vaccines in the Chinese market. The unethical conduct triggered widespread public anger and immediate government intervention. What actions could Changsheng take to mitigate the effect of this scandal? Thompson S.H. Teo is affiliated with National University of Singapore.

【書誌情報】

ページ数：9ページ

サイズ：A4

商品番号：HBSP-W19545

発行日：2019/9/27

登録日：2019/12/24